• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2019 o Market outlook: Forecast for 2019 - 2024 • Five Forces Analysis o Five forces summary o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Application o Market segments o Comparison by Application o Microbial and infectious disease testing - Market size and forecast 2019-2024 o Hematology testing - Market size and forecast 2019-2024 o Cardiac and lipid testing - Market size and forecast 2019-2024 o Coagulation testing - Market size and forecast 2019-2024 o Others - Market size and forecast 2019-2024 o Market opportunity by Application • Market Segmentation by End-users o Emergency care units o Operating rooms o ICUs • Customer Landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2019-2024 o Europe - Market size and forecast 2019-2024 o Asia - Market size and forecast 2019-2024 o ROW - Market size and forecast 2019-2024 o Key leading countries o Market opportunity by geography o Market drivers o Market challenges o Market trends • Vendor Landscape o Vendor landscape o Landscape disruption o Competitive scenario • Vendor Analysis o Vendors covered o Market positioning of vendors o Abbott Laboratories o bioMérieux SA o Bio-Rad Laboratories Inc. o Chembio Diagnostics Inc. o Danaher Corp. o EKF Diagnostics Holdings Plc o F. Hoffmann-La Roche Ltd. o Quidel Corp. o Siemens Healthineers AG • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibit • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Parent market • 9: Market characteristics • 10: Offerings of vendors included in the market definition • 11: Market segments • 12: Global - Market size and forecast 2019 - 2024 ($ million) • 13: Global market: Year-over-year growth 2019 - 2024 (%) • 14: Five forces analysis 2019 & 2024 • 15: Bargaining power of buyers • 16: Bargaining power of suppliers • 17: Threat of new entrants • 18: Threat of substitutes • 19: Threat of rivalry • 20: Market condition - Five forces 2019 • 21: Application - Market share 2019-2024 (%) • 22: Comparison by Application • 23: Microbial and infectious disease testing - Market size and forecast 2019-2024 ($ million) • 24: Microbial and infectious disease testing - Year-over-year growth 2019-2024 (%) • 25: Hematology testing - Market size and forecast 2019-2024 ($ million) • 26: Hematology testing - Year-over-year growth 2019-2024 (%) • 27: Cardiac and lipid testing - Market size and forecast 2019-2024 ($ million) • 28: Cardiac and lipid testing - Year-over-year growth 2019-2024 (%) • 29: Coagulation testing - Market size and forecast 2019-2024 ($ million) • 30: Coagulation testing - Year-over-year growth 2019-2024 (%) • 31: Others - Market size and forecast 2019-2024 ($ million) • 32: Others - Year-over-year growth 2019-2024 (%) • 33: Market opportunity by Application • 34: Customer landscape • 35: Market share by geography 2019-2024 (%) • 36: Geographic comparison • 37: North America - Market size and forecast 2019-2024 ($ million) • 38: North America - Year-over-year growth 2019-2024 (%) • 39: Europe - Market size and forecast 2019-2024 ($ million) • 40: Europe - Year-over-year growth 2019-2024 (%) • 41: Asia - Market size and forecast 2019-2024 ($ million) • 42: Asia - Year-over-year growth 2019-2024 (%) • 43: ROW - Market size and forecast 2019-2024 ($ million) • 44: ROW - Year-over-year growth 2019-2024 (%) • 45: Key leading countries • 46: Market opportunity by geography ($ million) • 47: Impact of drivers and challenges • 48: Vendor landscape • 49: Landscape disruption • 50: Industry risks • 51: Vendors covered • 52: Market positioning of vendors • 53: Abbott Laboratories - Overview • 54: Abbott Laboratories - Business segments • 55: Abbott Laboratories - Key offerings • 56: Abbott Laboratories - Key customers • 57: Abbott Laboratories - Segment focus • 58: Becton, Dickinson and Co. - Overview • 59: Becton, Dickinson and Co. - Business segments • 60: Becton, Dickinson and Co. - Key offerings • 61: Becton, Dickinson and Co. - Key customers • 62: Becton, Dickinson and Co. - Segment focus • 63: bioMérieux SA - Overview • 64: bioMérieux SA - Business segments • 65: bioMérieux SA - Key offerings • 66: bioMérieux SA - Key customers • 67: bioMérieux SA - Segment focus • 68: Bio-Rad Laboratories Inc. - Overview • 69: Bio-Rad Laboratories Inc. - Business segments • 70: Bio-Rad Laboratories Inc. - Key offerings • 71: Bio-Rad Laboratories Inc. - Key customers • 72: Bio-Rad Laboratories Inc. - Segment focus • 73: Chembio Diagnostics Inc. - Overview • 74: Chembio Diagnostics Inc. - Business segments • 75: Chembio Diagnostics Inc. - Key offerings • 76: Chembio Diagnostics Inc. - Key customers • 77: Chembio Diagnostics Inc. - Segment focus • 78: Danaher Corp. - Overview • 79: Danaher Corp. - Business segments • 80: Danaher Corp. - Key offerings • 81: Danaher Corp. - Key customers • 82: Danaher Corp. - Segment focus • 83: EKF Diagnostics Holdings Plc - Overview • 84: EKF Diagnostics Holdings Plc - Business segments • 85: EKF Diagnostics Holdings Plc - Key offerings • 86: EKF Diagnostics Holdings Plc - Key customers • 87: EKF Diagnostics Holdings Plc - Segment focus • 88: F. Hoffmann-La Roche Ltd. - Overview • 89: F. Hoffmann-La Roche Ltd. - Business segments • 90: F. Hoffmann-La Roche Ltd. - Key offerings • 91: F. Hoffmann-La Roche Ltd. - Key customers • 92: F. Hoffmann-La Roche Ltd. - Segment focus • 93: Quidel Corp. - Overview • 94: Quidel Corp. - Business segments • 95: Quidel Corp. - Key offerings • 96: Quidel Corp. - Key customers • 97: Quidel Corp. - Segment focus • 98: Siemens Healthineers AG - Overview • 99: Siemens Healthineers AG - Business segments • 100: Siemens Healthineers AG - Key offerings • 101: Siemens Healthineers AG - Key customers • 102: Siemens Healthineers AG - Segment focus • 103: Currency conversion rates for US$ • 104: Research Methodology • 105: Validation techniques employed for market sizing • 106: Information sources • 107: List of abbreviations

Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Chembio Diagnostics Inc., Danaher Corp., EKF Diagnostics Holdings Plc, F. Hoffmann-La Roche Ltd., Quidel Corp., Siemens Healthineers AG